Differential Expression of IFN-α and TRAIL/DR5 in Lymphoid Tissue of Progressor versus Nonprogressor HIV-1-Infected Patients

Loss of$CD4^{+}$T cells, the hallmark of HIV pathogenesis, was suggested to be partly due to apoptosis. We recently reported that IFN-α produced by HIV-1-activated plasmacytoid dendritic cells (pDCs) contributes to$CD4^{+}$T cell apoptosis by the TNF-related apoptosis-inducing ligand (TRAIL)/death r...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 103; no. 18; pp. 7000 - 7005
Main Authors Herbeuval, Jean-Philippe, Nilsson, Jakob, Boasso, Adriano, Hardy, Andrew W., Kruhlak, Michael J., Anderson, Stephanie A., Dolan, Matthew J., Dy, Michel, Andersson, Jan, Shearer, Gene M.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 02.05.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Loss of$CD4^{+}$T cells, the hallmark of HIV pathogenesis, was suggested to be partly due to apoptosis. We recently reported that IFN-α produced by HIV-1-activated plasmacytoid dendritic cells (pDCs) contributes to$CD4^{+}$T cell apoptosis by the TNF-related apoptosis-inducing ligand (TRAIL)/death receptor (DR)5 pathway. Here, we show that HIV-1-induced intracellular expression of IFN-α in pDCs is coupled to increased expression of IFN regulatory factor 7 and MyD88 by pDCs in vivo and in vitro. Expression of IFN-α was increased in lymphoid tonsillar tissue (LT) of patients with progressive ($HIV_{prog}$) compared with nonprogressive ($HIV_{NP}$) HIV-1 disease and to uninfected controls. LT from$HIV_{prog}$exhibited higher TRAIL and DR5 mRNA levels than LT from$HIV_{NP}$or controls. TRAIL mRNA levels in LT correlated with plasma viral load. We show that HIV-1 induces IFN-α and the TRAIL/DR5 apoptotic pathway in LT, suggesting a role for these cytokines in HIV-1 immunopathogenesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC1444883
Edited by Michael Sela, Weizmann Institute of Science, Rehovot, Israel, and approved March 2, 2006
Author contributions: J.-P.H. and G.M.S. designed research; J.-P.H., J.N., A.B., A.W.H., M.J.K., and J.A. performed research; J.-P.H., J.N., A.W.H., S.A.A., M.J.D., M.D., and J.A. contributed new reagents/analytic tools; and J.-P.H., J.N., A.B., M.J.K., S.A.A., M.J.D., M.D., J.A., and G.M.S. analyzed data.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0600363103